Clinical Trials Browser

Nelfinavir × Clear all

NCT04169763 2026-05-20

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Phase 1 Recruiting

Vulvar Neoplasms

NCT05036226 2026-05-13

COAST

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

NCT03256916 2026-02-24

NELCER

Phase 3 Completed

Uterine Cervical Neoplasms

NCT06971744 2025-12-22

Autophagy Maintenance (AUTOMAIN)

Phase 2 Recruiting

Ovarian Neoplasms

NCT03077451 2025-12-17

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

Phase 2 Completed

36 enrolled 13 charts

Sarcoma, Kaposi

NCT03829020 2024-08-22

Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma

Phase 1 Completed

Multiple Myeloma

NCT02024009 2024-07-25

SCALOP-2

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01068327 2023-10-10

Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01959672 2023-10-10

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Phase 2 Completed

11 enrolled 12 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02207439 2023-07-25

Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

18 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck

NCT00003008 2023-06-15

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase 2 Completed

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

NCT01555281 2022-07-07

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma

Phase 1/2 Terminated

Multiple Myeloma

NCT03050060 2022-06-22

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Phase 2 Terminated

21 enrolled 12 charts

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT01108666 2021-07-07

Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)

Phase 2 Terminated

7 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT01925378 2020-11-12

A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia

Phase 2 Withdrawn

Uterine Cervical Dysplasia

NCT00589056 2020-04-24

Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Phase 1/2 Completed

55 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02363829 2020-04-06

A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)

Phase 1 Completed

Acidemia, isovaleric, Uterine Cervical Neoplasms

NCT01445106 2019-12-17

A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors

Phase 1 Completed

Neoplasms

NCT01065844 2019-10-09

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

Phase 2 Completed

15 enrolled 3 charts

Carcinoma, Adenoid Cystic, Head and Neck Neoplasms

NCT02188537 2019-06-26

Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma

Phase 2 Completed

Neoplasms, Plasma Cell

NCT01164709 2019-05-15

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

Phase 1 Completed

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Mycosis Fungoides, Sezary Syndrome, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

NCT00915694 2019-04-23

Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme

Phase 1 Terminated

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01020292 2019-04-12

A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma

Phase 1 Completed

Glioma

NCT01086332 2018-11-13

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

Phase 1 Terminated

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT03422874 2018-02-06

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Phase 1 Withdrawn

Lymphoma, Neoplasms

NCT00791336 2017-07-28

Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer

Phase 2 Terminated

1 enrolled 3 charts

Carcinoma, Non-Small-Cell Lung

NCT01447589 2016-06-23

NelfLung

Phase 1/2 Withdrawn

Lung Neoplasms

NCT02080416 2016-06-10

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Phase EARLY_PHASE1 Terminated

GastrointestinalHead & NeckLymphoidSarcoma

Castleman Disease, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Neoplasms, Sarcoma, Sarcoma, Kaposi, Stomach Neoplasms

NCT01485731 2015-06-03

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

Phase 1 Completed

Adenocarcinoma, Uterine Cervical Neoplasms, Neoplasms

NCT00694837 2015-04-10

Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma

Phase 1 Completed

Glioblastoma

NCT00233948 2015-04-01

Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma

Phase 1/2 Terminated

29 enrolled 7 charts

Liposarcoma, Sarcoma

NCT00704600 2014-12-08

Nelfinavir

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT01079286 2013-07-15

I-NET

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms

NCT00002185 2005-06-24

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

Phase 2 Completed

DermatologicSarcoma

Sarcoma, Kaposi, Skin Neoplasms, HIV Infections, AIDS-Related Opportunistic Infections